2009 A Pan-Canadian Clinical Practice Guideline: Assessment of Psychosocial Health Care Needs of the Adult Cancer Patient

Note:

1) next update is 2014;

2) a quick search reveals that data was:

included for:        breast,colorectal,lung,prostate
not included for:  ovarian,brain,pancreatic,leukemia,lymphoma

CCAC_Research January 15, 2010 Section 10. ColoMarker

Note/Warning: very graphic images included in this newsletter

Section 10: ColoMarker Tests for Colon Cancer (Dec. 17/09)

Dec 2009: Colorectal Cancer Association of Canada - DNA stool tests for colorectal cancer

DNA stool test A DNA stool test screens stool for DNA mutations, indicating the presence of precancerous polyps or colon cancer"

* Pros: No dietary changes are required before the test. There’s no need to empty the colon ahead of time. Stool sample collection can be done at home.

* Cons: The test currently screens for a limited number of DNA mutations in stool. The test hasn’t been universally accepted as a screening tool for colon cancer. False-negative results are possible.

Search of: ovarian cancer | Adult | received from 01/01/2010 to 02/07/2010 - List Results - ClinicalTrials.gov

Search of: 'ovarian cancer' received from 01/01/2010 to 02/07/2010 - List Results = 11

Does risk-reducing bilateral salpingo-oophorectomy leaved behind residual tube?

Abstract
Objective
Risk-reducing bilateral salpingo-oophorectomy (RRSO) is an effective option for women with BRCA mutations however there is limited information as to how much tubal epithelium remains after RRSO.

Operating from the Other Side of the Table: Control Dynamics and the Surgeon Educator